504 related articles for article (PubMed ID: 18987152)
1. Differential expression of the CXCR3 ligands in chronic hepatitis C virus (HCV) infection and their modulation by HCV in vitro.
Helbig KJ; Ruszkiewicz A; Lanford RE; Berzsenyi MD; Harley HA; McColl SR; Beard MR
J Virol; 2009 Jan; 83(2):836-46. PubMed ID: 18987152
[TBL] [Abstract][Full Text] [Related]
2. Expression of the CXCR3 ligand I-TAC by hepatocytes in chronic hepatitis C and its correlation with hepatic inflammation.
Helbig KJ; Ruszkiewicz A; Semendric L; Harley HA; McColl SR; Beard MR
Hepatology; 2004 May; 39(5):1220-9. PubMed ID: 15122750
[TBL] [Abstract][Full Text] [Related]
3. Chemokine and chemokine receptor interactions provide a mechanism for selective T cell recruitment to specific liver compartments within hepatitis C-infected liver.
Shields PL; Morland CM; Salmon M; Qin S; Hubscher SG; Adams DH
J Immunol; 1999 Dec; 163(11):6236-43. PubMed ID: 10570316
[TBL] [Abstract][Full Text] [Related]
4. Synergistic induction of CXCL9 and CXCL11 by Toll-like receptor ligands and interferon-gamma in fibroblasts correlates with elevated levels of CXCR3 ligands in septic arthritis synovial fluids.
Proost P; Verpoest S; Van de Borne K; Schutyser E; Struyf S; Put W; Ronsse I; Grillet B; Opdenakker G; Van Damme J
J Leukoc Biol; 2004 May; 75(5):777-84. PubMed ID: 14996826
[TBL] [Abstract][Full Text] [Related]
5. The role of chemokines as inflammatory mediators in chronic hepatitis C virus infection.
Zeremski M; Petrovic LM; Talal AH
J Viral Hepat; 2007 Oct; 14(10):675-87. PubMed ID: 17875002
[TBL] [Abstract][Full Text] [Related]
6. Serum chemokine receptor CXCR3 ligands are associated with progression, organ dysfunction and complications of chronic liver diseases.
Tacke F; Zimmermann HW; Berres ML; Trautwein C; Wasmuth HE
Liver Int; 2011 Jul; 31(6):840-9. PubMed ID: 21645215
[TBL] [Abstract][Full Text] [Related]
7. Molecular profiling of early stage liver fibrosis in patients with chronic hepatitis C virus infection.
Bièche I; Asselah T; Laurendeau I; Vidaud D; Degot C; Paradis V; Bedossa P; Valla DC; Marcellin P; Vidaud M
Virology; 2005 Feb; 332(1):130-44. PubMed ID: 15661146
[TBL] [Abstract][Full Text] [Related]
8. The role of CCR5/CXCR3 expressing CD8+ cells in liver damage and viral control during persistent hepatitis C virus infection.
Larrubia JR; Calvino M; Benito S; Sanz-de-Villalobos E; Perna C; Pérez-Hornedo J; González-Mateos F; García-Garzón S; Bienvenido A; Parra T
J Hepatol; 2007 Nov; 47(5):632-41. PubMed ID: 17560677
[TBL] [Abstract][Full Text] [Related]
9. Peripheral CXCR3-associated chemokines as biomarkers of fibrosis in chronic hepatitis C virus infection.
Zeremski M; Dimova R; Brown Q; Jacobson IM; Markatou M; Talal AH
J Infect Dis; 2009 Dec; 200(11):1774-80. PubMed ID: 19848607
[TBL] [Abstract][Full Text] [Related]
10. Chlamydophila pneumoniae induces production of the defensin-like MIG/CXCL9, which has in vitro antichlamydial activity.
Balogh EP; Faludi I; Virók DP; Endrész V; Burián K
Int J Med Microbiol; 2011 Mar; 301(3):252-9. PubMed ID: 21056004
[TBL] [Abstract][Full Text] [Related]
11. A CXC chemokine sequence isolated from the rainbow trout Oncorhynchus mykiss resembles the closely related interferon-gamma-inducible chemokines CXCL9, CXCL10 and CXCL11.
Laing KJ; Bols N; Secombes CJ
Eur Cytokine Netw; 2002; 13(4):462-73. PubMed ID: 12517732
[TBL] [Abstract][Full Text] [Related]
12. Phenotypic and functional characterization of intrahepatic T lymphocytes during chronic hepatitis C.
Leroy V; Vigan I; Mosnier JF; Dufeu-Duchesne T; Pernollet M; Zarski JP; Marche PN; Jouvin-Marche E
Hepatology; 2003 Oct; 38(4):829-41. PubMed ID: 14512870
[TBL] [Abstract][Full Text] [Related]
13. IL-18 enhances IFN-gamma-induced production of CXCL9, CXCL10, and CXCL11 in human keratinocytes.
Kanda N; Shimizu T; Tada Y; Watanabe S
Eur J Immunol; 2007 Feb; 37(2):338-50. PubMed ID: 17274000
[TBL] [Abstract][Full Text] [Related]
14. [Expressions of CXCL9, CXCL10 and CXCL11 in renal tubular epithelial cells induced by IFN-γ].
Lin Q; Song Y; Zhu X; Yang S; Zheng J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Feb; 29(2):137-40. PubMed ID: 23388331
[TBL] [Abstract][Full Text] [Related]
15. Review: The chemokine receptor CXCR3 and its ligands CXCL9, CXCL10 and CXCL11 in neuroimmunity--a tale of conflict and conundrum.
Müller M; Carter S; Hofer MJ; Campbell IL
Neuropathol Appl Neurobiol; 2010 Aug; 36(5):368-87. PubMed ID: 20487305
[TBL] [Abstract][Full Text] [Related]
16. The relative activity of CXCR3 and CCR5 ligands in T lymphocyte migration: concordant and disparate activities in vitro and in vivo.
Stanford MM; Issekutz TB
J Leukoc Biol; 2003 Nov; 74(5):791-9. PubMed ID: 12960247
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-27 and IFNγ regulate the expression of CXCL9, CXCL10, and CXCL11 in hepatitis.
Basset L; Chevalier S; Danger Y; Arshad MI; Piquet-Pellorce C; Gascan H; Samson M
J Mol Med (Berl); 2015 Dec; 93(12):1355-67. PubMed ID: 26199110
[TBL] [Abstract][Full Text] [Related]
18. CCR3 functional responses are regulated by both CXCR3 and its ligands CXCL9, CXCL10 and CXCL11.
Xanthou G; Duchesnes CE; Williams TJ; Pease JE
Eur J Immunol; 2003 Aug; 33(8):2241-50. PubMed ID: 12884299
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of alpha-chemokines IP-10, I-TAC, and MIG are differentially regulated in human corneal keratocytes.
McInnis KA; Britain A; Lausch RN; Oakes JE
Invest Ophthalmol Vis Sci; 2005 May; 46(5):1668-74. PubMed ID: 15851567
[TBL] [Abstract][Full Text] [Related]
20. Increased expression of T cell chemokines and their receptors in chronic hepatitis C: relationship with the histological activity of liver disease.
Apolinario A; Majano PL; Alvarez-Pérez E; Saez A; Lozano C; Vargas J; García-Monzón C
Am J Gastroenterol; 2002 Nov; 97(11):2861-70. PubMed ID: 12425561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
